Genetic Study of Brain Tumors in Young Children
INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors
Sponsor: National Cancer Institute (NCI)
Terminated
Poor accrual
Other terminated trials from National Cancer Institute (NCI)
This observational or N/A phase trial investigates Central Nervous System Tumor, Pediatric and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 11 recorded versions since 2001 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Mar 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Pediatric Brain Tumor Consortium
For direct contact, visit the study record on ClinicalTrials.gov .